36% pain reduction vs. 10% standard care. 55% medication reduction. The evidence-based PEMF protocol for Total Hip Arthroplasty (THA) rehabilitation — faster ambulation, controlled swelling, reduced analgesic dependence.
July 2026 · 10 min read · Post-Surgical Rehabilitation Protocol
Total Hip Arthroplasty (THA) is one of the most consistently successful orthopedic procedures — but the 6–12 week post-surgical window determines long-term functional outcome. During this period, three parallel tissue processes occur simultaneously: bone integration of the prosthetic components, soft tissue healing (capsule, short external rotators, gluteal attachments), and neuromuscular re-education of gait mechanics. Inadequate management of any one of these three processes results in delayed ambulation, persistent pain, and increased risk of prosthetic loosening.
In the Philippines, an estimated 12,000–18,000 THAs are performed annually, with demand growing at 8–12% per year as the over-60 population increases and access to orthopedic surgery expands. Each patient requires 8–16 weeks of structured rehabilitation — creating a high-volume, recurring revenue stream for rehabilitation clinics equipped with appropriate technology.
PEMF does not replace physiotherapy or exercise rehabilitation — it operates through biophysical mechanisms that enhance the tissue environment, making active rehabilitation more effective at every stage.
The primary multicenter randomized controlled trial (PMC11914662, n=91 completers, 5 orthopedic clinics) established the benchmark figures for PEMF in joint and soft-tissue pain management:
For post-THA specifically, a systematic review of PEMF in total joint arthroplasty (PubMed 32572365) confirmed reduced swelling index scores, earlier achievement of independent ambulation milestones, and lower 6-week VAS scores in PEMF-supplemented rehabilitation cohorts. These findings are consistent across knee and hip arthroplasty populations.
| Parameter | PEMF | Ice / Compression | NSAIDs | Ultrasound Therapy | Physiotherapy Alone |
|---|---|---|---|---|---|
| Pain reduction (RCT data) | 36% vs. 10% control | Modest, short-term only | Variable; GI risk | Moderate | 10% (control benchmark) |
| Medication reduction | 55% | None | N/A (is medication) | Limited data | 12% |
| Supports osseointegration | Yes (510k cleared) | No | No (may impair) | Limited evidence | Indirectly |
| Deep tissue reach | Yes (3–8 cm depth) | Superficial only | Systemic (all tissues) | 1–5 cm | Mechanical only |
| Adverse effects | Very rare | Frostbite risk if prolonged | GI, cardiovascular, renal | Minimal | Minimal |
| Operator time per session | Low (passive treatment) | Minimal | None | Moderate | High (1:1 supervised) |
| Philippine session cost | ₱1,500–₱2,500 | Minimal | ₱200–₱800/day | ₱500–₱1,500 | ₱800–₱1,500 |
The Philippine orthopedic rehabilitation market is experiencing structural growth driven by three factors: an aging population (the 65+ cohort will reach 8.9 million by 2030), expanding PhilHealth coverage for joint replacement procedures, and a growing middle class with access to elective surgery. THA patients are high-engagement rehabilitation users — they are motivated, have already invested significantly in their health, and complete full treatment courses at rates exceeding 80%.
70+ Israeli clinics (population: 9M) — now expanding to the Philippines — have demonstrated that PEMF-augmented post-joint-replacement rehabilitation achieves faster discharge milestones and generates higher patient satisfaction scores than physiotherapy-only protocols. Average THA rehabilitation course: 12–18 sessions across 8–10 weeks at ₱1,500–₱2,500/session.
PEMF is contraindicated in patients with active cardiac pacemakers (device interference risk), active malignancy in the treatment field, pregnancy, and active epilepsy with recent seizure activity. THA-specific note: modern titanium and cobalt-chromium alloy implants are non-ferromagnetic and do not interact with clinical PEMF frequencies — use of PEMF over a hip prosthesis is safe and is established practice in clinical orthopedic rehabilitation.
Yes. PEMF is most effective when administered before physiotherapy exercise sessions — the anti-inflammatory and analgesic effect reduces the pain barrier during active mobilization, enabling a greater range of motion during the session. Standard scheduling: 20–30 minutes of PEMF, then physiotherapy immediately following.
PEMF can begin as early as post-operative Day 1, provided the surgical wound is intact and there is no active bleeding. Early initiation (Day 1–3) has been associated with faster edema resolution and earlier weight-bearing milestones in joint arthroplasty literature.
No. All modern THA implant materials (titanium alloy, cobalt-chromium, UHMWPE polyethylene) are non-ferromagnetic. Clinical PEMF systems operate at field intensities that do not exert meaningful force on metallic implant components. This is distinct from MRI, which uses static magnetic fields many orders of magnitude stronger. PEMF post-arthroplasty is safe and is routinely used in orthopedic rehabilitation units in Israel, Europe, and North America.
PainFree Philippines is now onboarding rehabilitation clinic partners in Metro Manila and key provincial cities. Request the full investor and clinical operator brief — including device specifications, training program, revenue projections, and case studies from the 70+ Israeli clinic network.
Request Investment Brief →